OA-14 Persistent bone marrow and imaging MRD negativity may guide the duration of lenalidomide maintenance following ASCT in patients with multiple myeloma

Clinical Lymphoma, Myeloma & Leukemia(2023)

引用 0|浏览1
暂无评分
关键词
multiple myeloma,lenalidomide maintenance,bone marrow
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要